C039P: Abciximab Biosimilar (Research Grade), Anti-human Glycoprotein IIb/IIIa Receptor Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody abciximab biosimilar specifically binds to the human Glycoprotein IIb/IIIa Receptor protein.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by abciximab.C003P: Adalimumab Biosimilar, TNF alpha Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody adalimumab biosimilar specifically binds to the human TNF alpha.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by adalimumab.C040P: Alemtuzumab Biosimilar, CD52 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody alemtuzumab biosimilar specifically binds to the human CD52, a protein present on the surface of mature lymphocytes.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by alemtuzumab.C001P: Bevacizumab Biosimilar, Human VEGF Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody generated from the same parent mouse antibody as ranibizumab.
Specificity/Sensitivity: The monoclonal antibody bevacizumab biosimilar specifically binds to the human VEGF-A.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by bevacizumab.BP005287: Biotinylated Human TNF alpha Protein with the C-His-Avi Tag
Source: The recombinant Biotinylated Human TNF alpha Protein, (amino acids Val77-Leu233) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human TNF R2 protein with the C-His-Avi tag at 0.5 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Biotinylated Human TNF alpha protein with the C-His tag with the EC50 of 5.1 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.C002P: Cetuximab Biosimilar, Human EGFR Monoclonal Antibody
Recombinant Chimeric IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody cetuximab biosimilar specifically binds to the human EGFR.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by cetuximab.BP000484-C213: Recombinant Human C-Reactive Protein (CRP)
Source: E. coli-derived.
Purity: > 95% by reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000484-PRO-335: Recombinant Human C-Reactive Protein (CRP)
Source: E. coli-derived.
Purity: > 95.0% by RP-HPLC and SDS-PAGE.BP000484-PRO-557: Human C-Reactive Protein (CRP)
Source: Human Plasma-derived.
Purity: > 96%.BP000484-PRO-914: Recombinant Human C-Reactive Protein (19-224 a.a) (CRP)
Source: E. coli-derived.
Purity: > 90.0% by SDS-PAGE.